|
1
|
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y
and Kitajima M: Improvement in the results of surgical treatment of
advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surg. 232:225–232. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tachibana M, Kinugasa S, Yoshimura H,
Shibakita M, Tonomoto Y, Dhar DK and Nagasue N: Clinical outocomes
of extended esophagectomy with three-field lymph node dissection
for esophageal squamous cell carcinoma. Am J Surg. 189:98–109.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimada H, Okazumi S, Matsubara H, Nabeya
Y, Shiratori T, Shimizu T, Shuto K, Hayashi H and Ochiai T: Impact
of the number and extent of positive lymph nodes in 200 patients
with thoracic esophageal squamous cell carcinoma after three-field
lymph node dissection. World J Surg. 30:1441–1449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Higuchi K, Koizumi W, Tanabe S, Sasaki T,
Katada C, Azuma M, Nakatani K, Ishido K, Naruke A and Ryu T:
Current management of esophageal squamous-cell carcinoma in Japan
and other countries. Gastrointest Cancer Res. 3:153–161.
2009.PubMed/NCBI
|
|
5
|
Grimm JC, Valero V III and Molena D:
Surgical indications and optimization of patients for resectable
esophageal malignancies. J Thorac Dis. 6:249–257. 2014.PubMed/NCBI
|
|
6
|
Reed CE: Surgical management of esophageal
carcinoma. The Oncologist. 4:96–105. 1999.
|
|
7
|
Hwang JE, Kim HN, Kim DE, Choi HJ, Jung
SH, Shim HJ, Bae WK, Hwang EC, Cho SH and Chung IJ: Prognostic
significance of a systemic inflammatory response in patients
receiving first-line palliative chemotherapy for recurred or
metastatic gastric cancer. BMC Cancer. 11:4892011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Urba S, Gatz J, Shen W, Hossain A, Winfree
K, Koustenis A, Peterson P and Cohen EE: Quality of life scores as
prognostic factors of overall survival in advanced head and neck
cancer: Analysis of a phase III randomized trial of pemetrexed plus
cisplatin versus cisplatin monotherapy. Oral Oncol. 48:723–729.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McMillan DC: The systemic
inflammation-based Glasgow Prognostic Score: A decade of experience
in patients with cancer. Cancer Treat Rev. 39:534–540. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kishiki T, Masaki T, Matsuoka H, Kobayashi
T, Suzuki Y, Abe N, Mori T and Sugiyama M: Modified Glasgow
prognostic score in patients with incurable stage IV colorectal
cancer. Am J Surg. 206:234–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chua W, Charles KA, Baracos VE and Clarke
SJ: Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in
patients with advanced colorectal cancer. Br J Cancer.
104:1288–1295. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamanaka T, Matsumoto S, Teramukai S,
Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of
neutrophils to lymphocytes is associated with patient prognosis in
advanced gastric cancer. Oncology. 73:215–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ubukata H, Motohashi G and Tabuchi T,
Nagata H, Konishi S and Tabuchi T: Evaluation of
interferon-γ/interleukin-4 ratio and neutrophil/lymphocyte ratio as
prognostic indicators in gastric cancer patients. J Surg Oncol.
102:742–747. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nozoe T, Kohno M, Iguchi T, Mori E, Maeda
T, Matsukuma A and Ezaki T: The prognostic nutritional index can be
a prognostic indicator in colorectal carcinoma. Surg Today.
42:532–535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikeguchi M, Urushibara S, Shimoda R,
Yamamoto M, Maeta Y and Ashida K: Inflammation-based prognostic
scores and nutritional prognostic index in patients with
locally-advanced unresectable colorectal cancer. World J Surg
Oncol. 12:2102014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsuchita Y, Onda M, Miyashita M and
Sasajima K: Serum level of cytokeratin 19 fragment (CYFRA 21–1)
indicates tumour stage and prognosis of squamous cell carcinoma of
the oesophagus. Med Oncol. 16:31–37. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nabeya Y, Shimada H, Okazumi S, Matsubara
H, Gunji Y, Suzuki T and Ochiai T: Serum cross-linked
carboxyterminal telopeptide of type I collagen (ICTP) as a
prognostic tumor marker in patients with esophageal squamous cell
carcinoma. Cancer. 94:940–949. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cao X, Zhang L, Feng GR, Yang J, Wang RY,
Li J, Zheng XM and Han YJ: Preoperative Cyfra21-1 and SCC-Ag serum
titers predict survival in patients with stage II esophageal
squamous cell carcinoma. J Transl Med. 10:1972012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda
M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al:
Surgery plus chemotherapy compared with surgery alone for localized
squamous cell carcinoma of the thoracic esophagus: A Japan Clinical
Oncology Group Study-JCOG9204. J Clin Oncol. 21:4592–4596. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fujiwara Y, Yoshikawa R, Kamikonya N,
Nakayama T, Kitani K, Tsujie M, Yukawa M, Inoue M and Yamamura T:
Trimodality therapy of esophagectomy plus neoadjuvant
chemoradiotherapy improves the survival of clinical stage II/III
esophageal squamous cell carcinoma patients. Oncol Rep. 28:446–452.
2012.PubMed/NCBI
|
|
21
|
Duan H, Zhang X, Wang FX, Cai MY, Ma GW,
Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, et al: Prognostic role of
neutrophil-lymphocyte ratio in operable esophageal squamous cell
carcinoma. World J Gastroenterol. 21:5591–5597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun P, Zhang F, Chen C, An X, Li YH, Wang
FH and Zhu ZH: Comparison of the prognostic values of various
nutritional parameters in patients with esophageal squamous cell
carcinoma from Southern China. J Thorac Dis. 5:484–491.
2013.PubMed/NCBI
|
|
23
|
Sobin LH and Wittekind CH: UICC TNM
classification of malignant tumours. 6th. Hoboken, New Jersey: John
Wiley & Sons; 2002
|
|
24
|
Vercauteren IM, Verleden SE, McDonough JE,
Vandermeulen E, Ruttens D, Lammertyn EJ, Bellon H, De Dycker E,
Doomes C, Yserbyt J, et al: CYFRA 21.1 in bronchoalveolar lavage of
idiopathic pulmonary fibrosis patients. Exp Lung Res. 41:459–465.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hirahara N, Matsubara T, Hayashi H, Takai
K, Fujii Y and Tajima Y: Impact of inflammation-based prognostic
score on survival after curative thoracoscopic esophagectomy for
esophageal cancer. Eur J Surg Oncol. 41:1308–1315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yodying H, Matsuda A, Miyashita M,
Matsumoto S, Sakurazawa N, Yamada M and Uchida E: Prognostic
significance of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in oncologic outocomes of esophageal
cancer: A systematic review and meta-analysis. Ann Surg Oncol.
23:646–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu JS, Huang Y, Yang X and Feng JF: A
nomogram to predict prognostic values of various inflammatory
biomarkers in patients with esophageal squamous cell carcinoma. Am
J Cancer Res. 5:2180–2189. 2015.PubMed/NCBI
|
|
28
|
Han S, Liu Y, Li Q, Li Z, Hou H and Wu A:
Pre-treatment neutrophil-to-lymphocyte ratio is associated with
neutrophil and T-cell infiltration and predicts clinical outcome in
patients with glioblastoma. BMC Cancer. 15:6172015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bekes EM, Schweighofer B, Kupriyanova TA,
Zajac E, Ardi VC, Quigley JP and Deryugina EI: Tumor-recruited
neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately
the levels of tumor angiogenesis and efficiency of malignant cell
intravasation. Am J Pathol. 179:1455–1470. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dumitru CA, Lang S and Brandau S:
Modulation of neutrophil granulocytes in the tumor
microenvironment: Mechanisms and consequences for tumor
progression. Semin Cancer Biol. 23:141–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
